Crocin as a novel therapeutic agent against colitis
- 3 February 2019
- journal article
- research article
- Published by Taylor & Francis in Drug and Chemical Toxicology
- Vol. 43 (5) , 514-521
Abstract
Ulcerative colitis is a chronic inflammatory bowel disease with high incidence and prevalence worldwide. To investigate the therapeutic potency of crocin, as a pharmacologically active component of saffron, in dextran sodium sulfate (DSS)-induced colitis mice model. Experimental colitis was induced by 7-day administration of DSS dissolved in water at a concentration of 1.5% (w/v). The animals were randomly divided into four groups (n¼6 for each group). (1) Control group received regular drinking water for four weeks, (2) the second group of mice received regular drinking water for three weeks and then received DSS for one week, (3) and (4) the other two groups received 50-ppm or 200-ppm crocin for three weeks, respectively, and then treated with DSS for one week. Our results showed that Crocin attenuates colitis disease activity index including body weight loss, diarrhea, rectal bleeding, and colon shortening in crocin pre-tread mice. Comparison of histology of colon tissues between groups showed that crocin significantly decreases colon histopathological score, at least partially, by eliciting anti-inflammatory responses in DSS-induced colitis mice. These results clearly showed that crocin is a novel therapeutic agent with low toxicity as well as great clinical significance in treatment of colitis.Keywords
Funding Information
- Mashhad University of Medical Sciences (Grant No. 958349)
This publication has 35 references indexed in Scilit:
- Dietary Crocin Inhibits Colitis and Colitis-Associated Colorectal Carcinogenesis in Male ICR MiceEvidence-Based Complementary and Alternative Medicine, 2012
- Risk of Colorectal Cancer in Patients With Ulcerative Colitis: A Meta-analysis of Population-Based Cohort StudiesClinical Gastroenterology and Hepatology, 2012
- Effect of butyrate enemas on inflammation and antioxidant status in the colonic mucosa of patients with ulcerative colitis in remissionClinical Nutrition, 2010
- Effect of Moderate-Intensity Exercise on Plasma C-Reactive Protein and Aortic Endothelial Function in Type 2 Diabetic MiceMediators of Inflammation, 2010
- Use of in vitro assays to assess the potential antiproliferative and cytotoxic effects of saffron (Crocus sativus L.) in human lung cancer cell linePharmacognosy Magazine, 2010
- Safety evaluation of saffron (Crocus sativus) tablets in healthy volunteersPhytomedicine, 2008
- Crocin prevents the death of rat pheochromyctoma (PC-12) cells by its antioxidant effects stronger than those of α-tocopherolNeuroscience Letters, 2004
- The risk of colorectal cancer in ulcerative colitis: a meta-analysisGut, 2001
- The effect of antioxidant therapy on colonic inflammation in the ratZeitschrift für Die Gesamte Experimentelle Medizin, 1999
- Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention.Gut, 1994